Midwest Cancer Research Group, Inc.

Skokie, Illinois 60077

0 studies enrolling now · 6 studies all time

What they study most

Cerebroside Lipidosis Syndrome, Colorectal Cancer, Gaucher Disease, Non-Neuronopathic Form, Gaucher Disease, Type 1, Glucocerebrosidase Deficiency Disease, Glucosylceramide Beta-Glucosidase Deficiency Disease, Non Small Cell Lung Carcinoma, Ovarian Neoplasms, Pancreatic Cancer

Studies at this site

• Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer — Completed
• Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer — Completed
• Safety and Efficacy of Cerezyme® Infusions Every 4 Weeks Versus Every 2 Weeks in Type 1 Gaucher Disease — Completed
• TLK286 in Combination With Paraplatin (Carboplatin) in Recurrent Ovarian Cancer — Completed
• TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer — Completed
• Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer — Completed